Director of FSI “SID & GP” participated in the RegLek EAEU 2021 plenary session

For many years, the Conference has been a platform for an inter-agency dialogue, whereby the most pressing issues on expertise and drug registration are discussed, and each participant has an opportunity to receive topical information from representatives of federal government authorities, relevant organizations and industry experts. State Institute of Drugs and Good Practices has traditionally been taking part in the work of the Conference, our specialists are always ready to participate in the capacity of speakers of thematic sessions and describe the most interesting tendencies in the EAEU regulatory framework, and also to respond to the questions that are of significance to the industry.

In his welcoming speech, Vladislav Shestakov, Director of FSI “SID&GP” noted the high interest of the pharmaceutical community to the conference and briefly highlighted the situation with the formation of the EAEU single market of medicines circulation.

“Formation of a single market of the Union has been going on for more than a year. By now inspections are carried out according to unified procedures” – noted in his speech Vladislav Shestakov, Director of FSI “SID&GP”.

Vladislav Shestakov also told about the creation of the Eurasian Academy of Good Practices, which was opened on April 22, 2021, about the ongoing work on the formation of the management and teaching staff, about the development of the curriculum of the GxP-Academy. According to the plans of the founder, which is the FSI “SID&GP”, the training institution will start its work in September this year in a full format.